Anand Reddi


Anand Reddi is a researcher and global health specialist. He is known for his scholarly work on U.S. Global Health Policy including the President's Emergency Plan for AIDS Relief. His basic science research focuses on the molecular mechanisms involved in skin squamous cell cancer tumor initiation and metastasis. In 2005, Reddi was a Fulbright Scholar to South Africa. He served on the board of directors of the AIDS Healthcare Foundation from 2009-11.

Education

Anand Reddi is a graduate of the University of Michigan in Ann Arbor. He received a Fulbright Fellowship to South Africa assisting the Sinikithemba HIV/AIDS Center at McCord Hospital in Durban, KwaZulu-Natal. He studied medicine at the University of Colorado School of Medicine.

HIV Research

Reddi's research focuses on the provision of antiretroviral therapy in resource limited settings. His research in collaboration with Sarah Leeper resulted in one of the first studies that demonstrated that pediatric antiretroviral therapy is effective despite the challenges of a resource limited setting.

The Huffington Post

Reddi is a featured blogger on The Huffington Post writing on global health and U.S. domestic healthcare issues. In 2010 Reddi published an opinion-editorial article that brought attention to the flat-lining of global AIDS funds by U.S. President Barack Obama's administration. Within six hours, Ezekiel Emanuel, then senior adviser to President Obama for Health Policy, responded directly to Reddi by in the Huffington Post: "Contrary to what Dr. Reddi argues, neither I nor the Obama Administration sees an "either-or" trade-off between PEPFAR and other global health priorities such as improving maternal-child health." Reddi rebutted Emanuel's op-ed with a follow-up post that resulted in the restoration of $366 million for antiretroviral scale-up in Uganda.

AIDS Healthcare Foundation

In 2011, Reddi resigned from the Board of Directors of the AIDS Healthcare Foundation over a disagreement with AHF's opposition to Pre-exposure Prophylaxis. Reddi criticized AHF's claims against PrEP in an op-ed in The Huffington Post writing: "AHF’s media campaign against FDA review of PrEP is myopic, blinded by its determination to derail a promising new medication."

Human Capital Contracts

Reddi and Andreas Thyssen, while students at the University of Colorado School of Medicine, were the first to propose the use of human capital contracts to fund medical education in the United States in their article in The Huffington Post entitled: "". The Reddi-Thyssen plan resulted in legislation by the American Medical Association in support of human capital contracts. There is also a plan to use human capital contracts in global health. Thyssen and Reddi published a manuscript in AIDS advocating the use of human capital contracts to increase the number of healthcare workers educated in resource limited settings. Human capital contracts for global health mechanism is that an investor, such as a donor nation, charitable foundation, or global health initiative, will cover the entire cost of a student's medical training. In exchange, the student will work for the first 10 years of their medical career in a government or NGO sponsored health clinic in their respective country of medical education. Their medical license will be contingent on this obligatory national service. Additionally, a multilateral “binding” agreement between the African country and destination countries -brokered by the investor- could prevent migration during the term period.

Major Awards